Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 287

1.

Mycobacterium tuberculosis transmission in an ethnically-diverse high incidence region in England, 2007-11.

Vynnycky E, Keen AR, Evans JT, Khanom S, Hawkey PM, White RG, Abubakar I.

BMC Infect Dis. 2019 Jan 7;19(1):26. doi: 10.1186/s12879-018-3585-8.

2.

Acquisition and Loss of CTX-M-Producing and Non-Producing Escherichia coli in the Fecal Microbiome of Travelers to South Asia.

Bevan ER, McNally A, Thomas CM, Piddock LJV, Hawkey PM.

MBio. 2018 Dec 11;9(6). pii: e02408-18. doi: 10.1128/mBio.02408-18.

3.

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.

Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore D, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Williams HR, Goldenberg SD.

J Hosp Infect. 2018 Sep;100 Suppl 1:S1-S31. doi: 10.1016/j.jhin.2018.07.037. No abstract available.

PMID:
30173851
4.

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.

Mullish BH, Quraishi MN, Segal JP, McCune VL, Baxter M, Marsden GL, Moore DJ, Colville A, Bhala N, Iqbal TH, Settle C, Kontkowski G, Hart AL, Hawkey PM, Goldenberg SD, Williams HRT.

Gut. 2018 Nov;67(11):1920-1941. doi: 10.1136/gutjnl-2018-316818. Epub 2018 Aug 28.

5.

The 2017 Garrod Lecture: Genes, guts and globalization.

Hawkey PM.

J Antimicrob Chemother. 2018 Oct 1;73(10):2589-2600. doi: 10.1093/jac/dky277.

PMID:
30085107
6.

Increased Usage of Antiseptics Is Associated with Reduced Susceptibility in Clinical Isolates of Staphylococcus aureus.

Hardy K, Sunnucks K, Gil H, Shabir S, Trampari E, Hawkey P, Webber M.

MBio. 2018 May 29;9(3). pii: e00894-18. doi: 10.1128/mBio.00894-18.

7.

Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party.

Hawkey PM, Warren RE, Livermore DM, McNulty CAM, Enoch DA, Otter JA, Wilson APR.

J Antimicrob Chemother. 2018 Mar 1;73(suppl_3):iii2-iii78. doi: 10.1093/jac/dky027. Review.

PMID:
29514274
8.

CTX-M ESBL-producing Enterobacteriaceae: estimated prevalence in adults in England in 2014.

McNulty CAM, Lecky DM, Xu-McCrae L, Nakiboneka-Ssenabulya D, Chung KT, Nichols T, Thomas HL, Thomas M, Alvarez-Buylla A, Turner K, Shabir S, Manzoor S, Smith S, Crocker L, Hawkey PM.

J Antimicrob Chemother. 2018 May 1;73(5):1368-1388. doi: 10.1093/jac/dky007.

9.

The widespread dissemination of integrons throughout bacterial communities in a riverine system.

Amos GCA, Ploumakis S, Zhang L, Hawkey PM, Gaze WH, Wellington EMH.

ISME J. 2018 Mar;12(3):681-691. doi: 10.1038/s41396-017-0030-8. Epub 2018 Jan 26.

10.

Exposure to and colonisation by antibiotic-resistant E. coli in UK coastal water users: Environmental surveillance, exposure assessment, and epidemiological study (Beach Bum Survey).

Leonard AFC, Zhang L, Balfour AJ, Garside R, Hawkey PM, Murray AK, Ukoumunne OC, Gaze WH.

Environ Int. 2018 May;114:326-333. doi: 10.1016/j.envint.2017.11.003. Epub 2018 Jan 14.

11.

Effect of general practice characteristics and antibiotic prescribing on Escherichia coli antibiotic non-susceptibility in the West Midlands region of England: a 4 year ecological study.

Ironmonger D, Edeghere O, Verlander NQ, Gossain S, Hopkins S, Hilton B, Hawkey PM.

J Antimicrob Chemother. 2018 Mar 1;73(3):787-794. doi: 10.1093/jac/dkx465.

PMID:
29309593
12.

Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK).

Woodford N, Xu-McCrae L, Mushtaq S, Wu HHT, Ellington MJ, Lancaster O, Davies F, Donaldson H, Rao GG, Verma A, Wareham DW, Ciesielczuk H, Stone GG, Irani PM, Bracher S, Hawkey PM.

J Antimicrob Chemother. 2018 Mar 1;73(3):698-702. doi: 10.1093/jac/dkx471.

PMID:
29253163
13.

Use of and microbial resistance to antibiotics in China: a path to reducing antimicrobial resistance.

Cui D, Liu X, Hawkey P, Li H, Wang Q, Mao Z, Sun J.

J Int Med Res. 2017 Dec;45(6):1768-1778. doi: 10.1177/0300060516686230. Epub 2017 Jan 30. Review.

14.

Informing future research for carriage of multiresistant Gram-negative bacteria: problems with recruiting to an English stool sample community prevalence study.

Lecky DM, Nakiboneka-Ssenabulya D, Nichols T, Hawkey P, Turner K, Chung KT, Thomas M, Thomas HL, Xu McCrae L, Shabir S, Manzoor S, Alvarez-Buylla A, Smith S, McNulty C.

BMJ Open. 2017 Dec 10;7(12):e017947. doi: 10.1136/bmjopen-2017-017947.

15.

Community-acquired pneumonia in the United Kingdom: a call to action.

Chalmers J, Campling J, Ellsbury G, Hawkey PM, Madhava H, Slack M.

Pneumonia (Nathan). 2017 Oct 5;9:15. doi: 10.1186/s41479-017-0039-9. eCollection 2017.

16.

Disease Burden of Clostridium difficile Infections in Adults, Hong Kong, China, 2006-2014.

Ho J, Dai RZW, Kwong TNY, Wang X, Zhang L, Ip M, Chan R, Hawkey PMK, Lam KLY, Wong MCS, Tse G, Chan MTV, Chan FKL, Yu J, Ng SC, Lee N, Wu JCY, Sung JJY, Wu WKK, Wong SH.

Emerg Infect Dis. 2017 Oct;23(10):1671-1679. doi: 10.3201/eid2310.170797.

17.

Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong.

Ip M, Lai CK, Fung KSC, Wong KT, Zhu C, Van de Velde S, Tsang DN, Hawkey P.

Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2491-2494. doi: 10.1007/s10096-017-3091-8. Epub 2017 Aug 25.

18.

Investigation of community carriage rates of Clostridium difficile and Hungatella hathewayi in healthy volunteers from four regions of England.

Manzoor SE, McNulty CAM, Nakiboneka-Ssenabulya D, Lecky DM, Hardy KJ, Hawkey PM.

J Hosp Infect. 2017 Oct;97(2):153-155. doi: 10.1016/j.jhin.2017.05.014. Epub 2017 May 23.

PMID:
28549779
19.

Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype.

Bevan ER, Jones AM, Hawkey PM.

J Antimicrob Chemother. 2017 Aug 1;72(8):2145-2155. doi: 10.1093/jac/dkx146. Review.

PMID:
28541467
20.

Correction for Cairns et al., "Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages".

Cairns MD, Preston MD, Hall CL, Gerding DN, Hawkey PM, Kato H, Kim H, Kuijper EJ, Lawley TD, Pituch H, Reid S, Kullin B, Riley TV, Solomon K, Tsai PJ, Weese JS, Stabler RA, Wren BW.

J Clin Microbiol. 2017 Jun;55(6):1971. doi: 10.1128/JCM.00487-17. No abstract available.

21.

Is AGREE II a counsel of perfection? A letter commenting on Lytvyn et al.

Stone SP, Wilcox M, Hawkey P.

Infect Control Hosp Epidemiol. 2017 May;38(5):636-638. doi: 10.1017/ice.2017.5. Epub 2017 Apr 3. No abstract available.

PMID:
28367786
22.

Phylogenetic structure of European Salmonella Enteritidis outbreak correlates with national and international egg distribution network.

Dallman T, Inns T, Jombart T, Ashton P, Loman N, Chatt C, Messelhaeusser U, Rabsch W, Simon S, Nikisins S, Bernard H, le Hello S, Jourdan da-Silva N, Kornschober C, Mossong J, Hawkey P, de Pinna E, Grant K, Cleary P.

Microb Genom. 2016 Aug 25;2(8):e000070. doi: 10.1099/mgen.0.000070. eCollection 2016 Aug.

23.

Impact of long-term care facility residence on the antibiotic resistance of urinary tract Escherichia coli and Klebsiella.

Rosello A, Hayward AC, Hopkins S, Horner C, Ironmonger D, Hawkey PM, Deeny SR.

J Antimicrob Chemother. 2017 Apr 1;72(4):1184-1192. doi: 10.1093/jac/dkw555.

PMID:
28077671
24.

Characterization of carbapenemase-producing Enterobacteriaceae in the West Midlands region of England: 2007-14.

Findlay J, Hopkins KL, Alvarez-Buylla A, Meunier D, Mustafa N, Hill R, Pike R, McCrae LX, Hawkey PM, Woodford N.

J Antimicrob Chemother. 2017 Apr 1;72(4):1054-1062. doi: 10.1093/jac/dkw560.

PMID:
28073969
25.

Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages.

Cairns MD, Preston MD, Hall CL, Gerding DN, Hawkey PM, Kato H, Kim H, Kuijper EJ, Lawley TD, Pituch H, Reid S, Kullin B, Riley TV, Solomon K, Tsai PJ, Weese JS, Stabler RA, Wren BW.

J Clin Microbiol. 2017 Mar;55(3):865-876. doi: 10.1128/JCM.01296-16. Epub 2016 Dec 28. Erratum in: J Clin Microbiol. 2017 Jun;55(6):1971.

26.
27.

National survey of practice of faecal microbiota transplantation for Clostridium difficile infection in the UK.

Quraishi MN, Segal J, Mullish B, McCune VL, Hawkey P, Colville A, Williams H, Hart A, Iqbal TH.

J Hosp Infect. 2017 Apr;95(4):444-445. doi: 10.1016/j.jhin.2016.10.023. Epub 2016 Nov 3. No abstract available.

28.

Programmatic utility of tuberculosis cluster investigation using a social network approach in Birmingham, United Kingdom.

Munang ML, Browne C, Evans JT, Smith EG, Hawkey PM, Welch SB, Kaur H, Dedicoat MJ.

Int J Tuberc Lung Dis. 2016 Oct;20(10):1300-1305.

PMID:
27725038
29.

Genome and Plasmid Analysis of blaIMP-4-Carrying Citrobacter freundii B38.

Xiong J, Déraspe M, Iqbal N, Ma J, Jamieson FB, Wasserscheid J, Dewar K, Hawkey PM, Roy PH.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6719-6725. doi: 10.1128/AAC.00588-16. Print 2016 Nov.

30.

Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts.

Freeman R, Ironmonger D, Puleston R, Hopkins KL, Welfare W, Hope R, Staves P, Shemko M, Hopkins S, Cleary P, Patel B, Muller-Pebody B, Li X, Alvarez-Buylla A, Hawkey PM, Johnson AP, Woodford N, Oliver I.

Clin Microbiol Infect. 2016 Oct;22(10):896-897. doi: 10.1016/j.cmi.2016.07.020. Epub 2016 Jul 27. No abstract available.

31.

High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.

Wong SH, Ip M, Hawkey PM, Lo N, Hardy K, Manzoor S, Hui WW, Choi KW, Wong RY, Yung IM, Cheung CS, Lam KL, Kwong T, Wu WK, Ng SC, Wu JC, Sung JJ, Lee N.

J Infect. 2016 Aug;73(2):115-22. doi: 10.1016/j.jinf.2016.05.010. Epub 2016 May 28.

PMID:
27246801
32.
33.

Multidrug-resistant (MDR) Gram-negative bacteria information leaflets.

Brown C, Livermore DM, Otter JA, Warren RE, Jenks P, Enoch DA, Newsholme W, Oppenheim B, Leanord A, McNulty C, Tanner G, Bennett S, Cann M, Bostock J, Collins E, Peckitt S, Ritchie L, Fry C, Hawkey P, Wilson AP.

J Hosp Infect. 2016 Jan;92(1):86-7. No abstract available.

PMID:
27158703
34.

Multicentre evaluation of a real-time PCR assay to detect genes encoding clinically relevant carbapenemases in cultured bacteria.

Ellington MJ, Findlay J, Hopkins KL, Meunier D, Alvarez-Buylla A, Horner C, McEwan A, Guiver M, McCrae LX, Woodford N, Hawkey P.

Int J Antimicrob Agents. 2016 Feb;47(2):151-4. doi: 10.1016/j.ijantimicag.2015.11.013. Epub 2015 Dec 29.

PMID:
26795023
35.

Evaluation of CTX-M steady-state mRNA, mRNA half-life and protein production in various STs of Escherichia coli.

Geyer CN, Fowler RC, Johnson JR, Johnston B, Weissman SJ, Hawkey P, Hanson ND.

J Antimicrob Chemother. 2016 Mar;71(3):607-16. doi: 10.1093/jac/dkv388. Epub 2015 Nov 26.

36.

Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party.

Wilson AP, Livermore DM, Otter JA, Warren RE, Jenks P, Enoch DA, Newsholme W, Oppenheim B, Leanord A, McNulty C, Tanner G, Bennett S, Cann M, Bostock J, Collins E, Peckitt S, Ritchie L, Fry C, Hawkey P.

J Hosp Infect. 2016 Jan;92 Suppl 1:S1-44. doi: 10.1016/j.jhin.2015.08.007. Epub 2015 Nov 16. No abstract available.

PMID:
26598314
37.

Antibiotic surgical prophylaxis increases nasal carriage of antibiotic-resistant staphylococci.

McMurray CL, Hardy KJ, Verlander NQ, Hawkey PM.

J Med Microbiol. 2015 Dec;64(12):1489-95. doi: 10.1099/jmm.0.000182. Epub 2015 Oct 6.

PMID:
26445858
38.

Rapid draft sequencing and real-time nanopore sequencing in a hospital outbreak of Salmonella.

Quick J, Ashton P, Calus S, Chatt C, Gossain S, Hawker J, Nair S, Neal K, Nye K, Peters T, De Pinna E, Robinson E, Struthers K, Webber M, Catto A, Dallman TJ, Hawkey P, Loman NJ.

Genome Biol. 2015 May 30;16:114. doi: 10.1186/s13059-015-0677-2.

39.

Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.

Zhong YM, Liu WE, Liang XH, Li YM, Jian ZJ, Hawkey PM.

J Antimicrob Chemother. 2015 Aug;70(8):2223-7. doi: 10.1093/jac/dkv114. Epub 2015 May 9.

40.

Multidrug-resistant Gram-negative bacteria: a product of globalization.

Hawkey PM.

J Hosp Infect. 2015 Apr;89(4):241-7. doi: 10.1016/j.jhin.2015.01.008. Epub 2015 Feb 4. Review.

PMID:
25737092
41.

Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years.

Ironmonger D, Edeghere O, Bains A, Loy R, Woodford N, Hawkey PM.

J Antimicrob Chemother. 2015;70(6):1744-50. doi: 10.1093/jac/dkv043. Epub 2015 Mar 1.

PMID:
25733586
42.

The hidden resistome of retail chicken meat.

Amos GC, Carter A, Hawkey PM, Gaze WH, Wellington EM.

J Glob Antimicrob Resist. 2015 Mar;3(1):44-46. doi: 10.1016/j.jgar.2014.11.003. Epub 2015 Jan 14. No abstract available.

PMID:
27873650
43.

Tuberculosis microepidemics among dispersed migrants, Birmingham, UK, 2004-2013.

Munang ML, Browne C, Khanom S, Evans JT, Smith EG, Hawkey PM, Kunst H, Welch SB, Dedicoat MJ.

Emerg Infect Dis. 2015 Mar;21(3):524-7. doi: 10.3201/eid2103.140209.

44.

Validated predictive modelling of the environmental resistome.

Amos GC, Gozzard E, Carter CE, Mead A, Bowes MJ, Hawkey PM, Zhang L, Singer AC, Gaze WH, Wellington EM.

ISME J. 2015 Jun;9(6):1467-76. doi: 10.1038/ismej.2014.237. Epub 2015 Feb 13.

45.

An explosive outbreak of Streptococcus pneumoniae serotype-8 infection in a highly vaccinated residential care home, England, summer 2012.

Thomas HL, Gajraj R, Slack MP, Sheppard C, Hawkey P, Gossain S, Drew CM, Pebody RG.

Epidemiol Infect. 2015 Jul;143(9):1957-63. doi: 10.1017/S0950268814002490. Epub 2014 Oct 9.

PMID:
25298247
46.

Waste water effluent contributes to the dissemination of CTX-M-15 in the natural environment.

Amos GC, Hawkey PM, Gaze WH, Wellington EM.

J Antimicrob Chemother. 2014 Jul;69(7):1785-91. doi: 10.1093/jac/dku079. Epub 2014 May 5.

47.

How do hospital professionals involved in a randomised controlled trial perceive the value of genotyping vs. PCR-ribotyping for control of hospital acquired C. difficile infections?

Szczepura A, Manzoor S, Hardy K, Stallard N, Parsons H, Gossain S, Hawkey PM.

BMC Infect Dis. 2014 Mar 21;14:154. doi: 10.1186/1471-2334-14-154.

48.

Functional metagenomic analysis reveals rivers are a reservoir for diverse antibiotic resistance genes.

Amos GC, Zhang L, Hawkey PM, Gaze WH, Wellington EM.

Vet Microbiol. 2014 Jul 16;171(3-4):441-7. doi: 10.1016/j.vetmic.2014.02.017. Epub 2014 Feb 16.

49.

Faecal transplantation for the treatment of Clostridium difficile infection: a review.

McCune VL, Struthers JK, Hawkey PM.

Int J Antimicrob Agents. 2014 Mar;43(3):201-6. doi: 10.1016/j.ijantimicag.2013.10.009. Epub 2013 Nov 9. Review.

PMID:
24636428
50.

Extended-spectrum β-lactamase producing Klebsiella spp. in chicken meat and humans: a comparison of typing methods.

Overdevest IT, Heck M, van der Zwaluw K, Huijsdens X, van Santen M, Rijnsburger M, Eustace A, Xu L, Hawkey P, Savelkoul P, Vandenbroucke-Grauls C, Willemsen I, van der Ven J, Verhulst C, Kluytmans JA.

Clin Microbiol Infect. 2014 Mar;20(3):251-5. doi: 10.1111/1469-0691.12277. Epub 2013 Aug 19.

Supplemental Content

Loading ...
Support Center